Found: 12
Select item for more details and to access through your institution.
Impact of non‐obese metabolic dysfunction‐associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 201, doi. 10.1111/hepr.13973
- By:
- Publication type:
- Article
Cost‐effectiveness of hepatitis E virus vaccination strategy.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 122, doi. 10.1111/hepr.14000
- By:
- Publication type:
- Article
New concept in fatty liver diseases.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 125, doi. 10.1111/hepr.14004
- By:
- Publication type:
- Article
Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 189, doi. 10.1111/hepr.13971
- By:
- Publication type:
- Article
Deciphering the dual nature of the Fibrosis‐4 index in predicting hepatocellular carcinoma risk among hepatitis B patients undergoing nucleos(t)ide analog therapy.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 120, doi. 10.1111/hepr.13997
- By:
- Publication type:
- Article
Integrative prediction of metabolic dysfunction‐associated fatty liver disease by endogenous fructose and related metabolism.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 213, doi. 10.1111/hepr.13956
- By:
- Publication type:
- Article
Rho GTPase‐activating protein 1 promotes hepatocellular carcinoma progression via modulation by CircPIP5K1A/MiR‐101‐3p.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 174, doi. 10.1111/hepr.13972
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 117, doi. 10.1111/hepr.13914
- Publication type:
- Article
Weighted thyroid‐stimulating hormone disturbance in prognosis of hepatitis B virus‐related acute‐on‐chronic liver failure.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 151, doi. 10.1111/hepr.13970
- By:
- Publication type:
- Article
Significance of the autoantibody assay in predicting the development of immune‐related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 162, doi. 10.1111/hepr.13969
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 142, doi. 10.1111/hepr.13967
- By:
- Publication type:
- Article
Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 131, doi. 10.1111/hepr.13957
- By:
- Publication type:
- Article